Exact Sciences Corporation (EXAS)
Mar 23, 2026 - EXAS was delisted (reason: acquired by ABT)
104.91
+0.99 (0.95%)
Inactive · Last trade price on Mar 20, 2026
Exact Sciences Employees
Exact Sciences had 7,200 employees as of December 31, 2025. The number of employees increased by 200 or 2.86% compared to the previous year.
Employees
7,200
Change (1Y)
200
Growth (1Y)
2.86%
Revenue / Employee
$450,971
Profits / Employee
-$28,882
Market Cap
20.03B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,200 | 200 | 2.86% |
| Dec 31, 2024 | 7,000 | 400 | 6.06% |
| Dec 31, 2023 | 6,600 | 200 | 3.13% |
| Dec 31, 2022 | 6,400 | -100 | -1.54% |
| Dec 31, 2021 | 6,500 | 1,500 | 30.00% |
| Dec 31, 2020 | 5,000 | 890 | 21.65% |
| Dec 31, 2019 | 4,110 | 2,133 | 107.89% |
| Dec 31, 2018 | 1,977 | 709 | 55.91% |
| Dec 31, 2017 | 1,268 | 532 | 72.28% |
| Dec 31, 2016 | 736 | 59 | 8.71% |
| Dec 31, 2015 | 677 | 441 | 186.86% |
| Dec 31, 2014 | 236 | 134 | 131.37% |
| Dec 31, 2013 | 102 | 15 | 17.24% |
| Dec 31, 2012 | 87 | 26 | 42.62% |
| Dec 31, 2011 | 61 | 26 | 74.29% |
| Dec 31, 2010 | 35 | 16 | 84.21% |
| Dec 31, 2009 | 19 | 15 | 375.00% |
| Dec 31, 2008 | 4 | -10 | -71.43% |
| Dec 31, 2007 | 14 | -8 | -36.36% |
| Dec 31, 2006 | 22 | -27 | -55.10% |
| Dec 31, 2005 | 49 | -22 | -30.99% |
| Dec 31, 2004 | 71 | -11 | -13.41% |
| Dec 31, 2003 | 82 | 7 | 9.33% |
| Dec 31, 2002 | 75 | 7 | 10.29% |
| Dec 31, 2001 | 68 | 24 | 54.55% |
| Dec 31, 2000 | 44 | - | - |
EXAS News
- 2 months ago - Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026 - Business Wire
- 3 months ago - Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year - Business Wire
- 3 months ago - Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration - Business Wire
- 3 months ago - Exact Sciences Stockholders Approve Acquisition by Abbott - Business Wire
- 3 months ago - Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results - Business Wire
- 4 months ago - Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences' '746 Patent - Business Wire
- 4 months ago - Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests - Business Wire
- 4 months ago - Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide - Business Wire